Combination of structural
biology services and drug discovery capabilities aims to provide 'integrated solutions from one point of service and contact'
SANYO North America Corp.’s
Biomedical Solutions Division and BD Biosciences, a segment of Becton, Dickinson and Co., last month announced a strategic agreement to jointly promote
cutting-edge life science research tools designed to advance cell culture and cell therapy research.
Proteome Sciences PLC, a global leader in applied proteomics and peptidomics, has entered into a collaboration agreement
with the renowned Moffitt Cancer Center to develop mass spectrometry assays measuring certain key signaling and repair pathway proteins that can be adapted
for tumor biopsy analysis in the clinic.
Canada's Centre for Drug
Research and Development teams up with Germany's Lead Discovery Center to use basic research to develop 'promising innovations' for several diseases
Harvard Bioscience Inc., a global developer of tools for life science research and regenerative medicine, announced last month that it has
acquired the preclinical business unit of CMA Microdialysis AB through a purchase of assets.
In a supercharged business and regulatory climate, life sciences
companies large and small are turning to outsourcing vendors to manage tactical tasks and help them adopt best practices.
In the last month or so, I’ve read white papers, CEO speeches, editorials and op-eds
in response to what some now call a crisis in innovation, perhaps to mirror the purported crisis in education.
Isn’t it about time Congress revisited what is
essentially an afterthought on a 15-year-old appropriations bill, clearly articulated the facts and concerns about hESC research and put forth a specific
policy on the matter?
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.